AMOT:TASEAmot Investments Ltd. Analysis
Data as of 2026-03-17 - not real-time
€4.02
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Amotiv Limited is trading well below its longer‑term moving averages, with the price sitting under both the short‑term and medium‑term trends, indicating a bearish technical backdrop. The RSI is deep in oversold territory, suggesting a potential short‑term bounce, yet the MACD remains bearish, reinforcing downward momentum. The stock carries a high dividend yield that appears attractive, but the company is posting negative earnings and a modest revenue growth rate, raising questions about the sustainability of payouts. Valuation metrics point to a sizable gap between the current price and the discounted cash‑flow estimate, implying that the market may be undervaluing the business at present.
Despite a volatile price history and a beta above one, the firm benefits from a diversified geographic footprint across Australia, New Zealand, Asia and the United States, which can cushion regional downturns. However, the sizable debt load relative to equity and a negative profit margin amplify financial risk. Investors should weigh the appealing dividend against the earnings weakness and consider the stock as a potential value play if they are comfortable with the elevated risk profile.
Despite a volatile price history and a beta above one, the firm benefits from a diversified geographic footprint across Australia, New Zealand, Asia and the United States, which can cushion regional downturns. However, the sizable debt load relative to equity and a negative profit margin amplify financial risk. Investors should weigh the appealing dividend against the earnings weakness and consider the stock as a potential value play if they are comfortable with the elevated risk profile.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price below short‑term moving averages
- oversold RSI indicating limited upside
- persistent bearish MACD signal
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- valuation gap versus discounted cash‑flow estimate
- high dividend yield that could attract income investors
- potential for earnings improvement as cost structure stabilises
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- underlying asset value exceeds market price
- diversified geographic exposure supporting resilience
- opportunity for balance‑sheet deleveraging and profitability turn‑around
Key Metrics & Analysis
Financial Health
Revenue Growth3.30%
Profit Margin-9.20%
ROE-11.31%
ROA6.27%
Debt/Equity78.20
P/B Ratio1.2
Op. Cash Flow€168.8M
Free Cash Flow€98.3M
Technical Analysis
TrendBearish
RSI26.3
Support€4.00
Resistance€4.90
MA 20€4.42
MA 50€4.74
MA 200€4.85
MACDBearish
VolumeStable
Fear & Greed Index80.7
Valuation
Fair Value€7.41
GradeUndervalued
TypeValue
Dividend Yield6.11%
Risk Assessment
Beta1.28
Volatility32.39%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskHigh
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.